Kayabasi, HasanYilmaz, ZulfukarYildirim, IdrisYildirim, YasarKadiroglu, Ali KemalYilmaz, M. Emin2024-04-242024-04-2420111300-7718https://doi.org/10.5262/tndt.2011.1002.09https://hdl.handle.net/11468/20048OBJECTIVE: To evaluate the characteristics of patients with metabolic syndrome, and the association of developing MS with peritoneal dialysis duration among patients undergoing continuous ambulatory peritoneal dialysis. MATERIAL and METHODS: Fifty-eight nondiabetic CAPD patients were evaluated. Biochemical parameters, blood pressure, length, weight, waist circumference, and body mass indexes were recorded. MS was determined using NCP-ATP III criteria. The patients were divided into 3 groups according to dialysis duration (Group 1: <= 60 months, Group 2: 61-120 months, Group 3: >= 121 months) and the frequency of MS was compared. RESULTS: Twenty-four of 58 patients were male, and MS was present in 22 (37.9%) patients. 14 (82.4%) of 22 patients with MS were female, (p=0.544). There was a statistically significant difference between patients with and without MS regarding age, BMI, waist circumference, PD duration, and triglyceride levels (p<0.05). 55% (n=32) of the patients were in group 1, 34.5% (n=20) in group 2, and 10.5% (n=6) in group 3 (p=0.092). The frequency of MS decreased with prolongation of dialysis duration (50% in group 1, 20% in group 2, and 33,3% in group 3) (p<0.001). CONCLUSION: The frequency of MS among our CAPD patients was 37.9% and it decreased with prolongation of dialysis duration. This result may suggest that alterations in metabolic state, and abandoning glucose-based PD solutions may improve MS criteria.trinfo:eu-repo/semantics/closedAccessMetabolic SyndromePeritoneal DialysisMetabolismCardiovascular RiskArticle202168172WOS:0002171744000092-s2.0-8485787579410.5262/tndt.2011.1002.09N/AN/A